[1]中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) :324-329.
|
[2]程红春, 孙丽, 刘鹏, 等.肝穿刺活检术4449例临床分析[J].解放军医学杂志, 2005, 30 (4) :319.
|
[3]Lai M, Hyatt BJ, Nasser I, et al.The clinical significance of persistently normal ALT in chronic hepatitis B infection[J].Hepatology, 2007, 47 (6) :760-767.
|
[4]龙辉, 罗红涛, 赖春颜, 等.丙氨酸氨基转移酶低水平慢性乙型肝炎患者的肝脏病理分析[J].广东医学, 2008, 22 (10) :1672-1674.
|
[5]张玉果, 南月敏.慢性乙型肝炎临床与病理的对比分析[J].国际消化病杂志, 2007, 15 (6) :468-469.
|
[6] 施维群, 倪伟.60例肝病患者肝组织活检和临床诊断分析[J].中华临床感染病杂志, 2008, 1 (4) :227-228.
|
[1] | Han GuoRong. Diagnosis and treatment of chronic hepatitis B in women of child-bearing age and strategies for blocking mother-to-child transmission[J]. Journal of Clinical Hepatology, 2019, 35(7): 1417-1420. doi: 10.3969/j.issn.1001-5256.2019.07.001 |
[2] | Jiao DeChao, Lei QinYu, Han XinWei, Li ZongMing, Bi YongHua, Zhang QuanHui. Clinical value of ultra-thin electronic flexible endoscopy combined with intraluminal ultrasound in assisting percutaneous transhepatic biliary stricture biopsy[J]. Journal of Clinical Hepatology, 2019, 35(12): 2744-2747. doi: 10.3969/j.issn.1001-5256.2019.12.021 |
[3] | Wu DongBo, Chen EnQiang, Bai Lang, Tang Hong. Liver biopsy and related techniques in pathological diagnosis[J]. Journal of Clinical Hepatology, 2018, 34(11): 2295-2299. doi: 10.3969/j.issn.1001-5256.2018.11.006 |
[4] | Sun HaiYing, Wang YaJun, Wang Ming, Zhang ShuQin, Lyu ShengJun, Chen Hui. Liver biopsy results of chronic HBV carriers aged above 40 years: an analysis of 442 cases[J]. Journal of Clinical Hepatology, 2017, 33(8): 1479-1482. doi: 10.3969/j.issn.1001-5256.2017.08.013 |
[5] | Liang XieEr, Chen YongPeng. Role of liver fibrosis assessment in decision-making and efficacy surveillance for antiviral therapy in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(11): 2058-2061. doi: 10.3969/j.issn.1001-5256.2016.11.008 |
[6] | Feng GuangShuai, Pan Ling, Feng QuanSheng. Correlation between HBV DNA load and ALT level: analysis of 800 patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(5): 421-423. doi: 10.3969/j.issn.1001-5256.2014.05.009 |
[7] | Shi MeiJie, Zhang ChaoZhen, Chi XiaoLing, Xie YuBao, Xiao HuanMing. Analysis of clinical high-risk factors for hepatitis B cirrhosis confirmed by liver biopsy[J]. Journal of Clinical Hepatology, 2014, 30(2): 149-152. doi: 10.3969/j.issn.1001-5256.2014.02.013 |
[8] | Xu XiuHua, Xiang XiaoXing, Long AiHua, Liu Dan, Wang JingSong. Differential distribution of age and HBV serological markers in liver cirrhosis and non-cirrhotic patients with primary liver cancer[J]. Journal of Clinical Hepatology, 2013, 29(3): 214-216. |
[9] | Liu XingXiang, Li GuiZhen, Xu YunFang, Zhang Jing. Relationship between HBV DNA and HBeAg in serum and HBcAg and inflammation grade in liver tissue among patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2013, 29(12): 919-921. doi: 10.3969/j.issn.1001-5256.2013.12.011 |
[10] | Zhang Zheng, Wang FuSheng. Current perspectives on immune pathogenesis and immune therapy of chronic hepatitis B [J]. Journal of Clinical Hepatology, 2012, 28(11): 801-804. |
[11] | Liu Cheng, Mu YongPing, Yang ZongGuo, Chen XiaoRong. Clinical significance of monitoring hepatitis B virus core-related antigens [J]. Journal of Clinical Hepatology, 2012, 28(10): 793-796. |
[12] | Zhang JianJun, Wu LiPing, Du RuiQing, Wang JianBin, Yao ZhanCheng, Yu GuiQin. Factors correlating with the liver inflammation grade ≥G2 in chronic HBV-infected patients with normal liver function[J]. Journal of Clinical Hepatology, 2012, 28(1): 35-38. |
[13] | Wang HaiYan, Wang Yu, Peng XiaoMing, Liu Ya. Recent advancement of telbivudine in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(12): 1320-1322+1326. |
[14] | Pan Lei, Wei Xin, Xie YuMei, Hao ChunQiu, Wang JiuPing, Jia ZhanSheng, Bai XueFan. Anti-viral therapy with pegylated interferon alpha-2a plus ribavirin in patients co-infected with HBV and HCV[J]. Journal of Clinical Hepatology, 2011, 27(1): 84-85+95. |
[15] | Xiong QiXiang, Xiong LiJuan. Hepatitis B virus infection and DNA methylation in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(8): 881-884. |
[16] | Zou XiaoJing, Jiang XueQiang, Tian DeYing. Role of DC-SIGN on the maturation and activation of dendritic cells in chronic hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2011, 27(2): 145-147+153. |
[17] | Chen Wei, Ding Yang, Sheng QiuJu, Dou XiaoGuang. HBV mother-to-child transmission block-agreement and controversy[J]. Journal of Clinical Hepatology, 2011, 27(12): 1259-1261. |
[18] | Zhuang Lin, You Jing, Lei Hua, Li YunLi, Kong Lei, Wang QingQing, Hu MingFen, Bo BaoLi. Study of liver pathology in mild ALT - elevated chronic hepatitis B patients with different HBV DNA levels[J]. Journal of Clinical Hepatology, 2011, 27(12): 1278-1281+1284. |
[19] | Niu ChunYan, Gao BaoHua, Zheng JianYun, Wu FangXiong, Wang Wen, Luo JianMei, Zheng NaiQing. The correlations between HBV quantity in the liver tissue and the severity of liver tissue injury in chronic hepatitis B and hepatic cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(3): 277-279. |
[20] | Zhu LongDong, Yuan Hong, Chen Lin. Pathological and clinical analysis of chronic asymptomatic HBV carriers[J]. Journal of Clinical Hepatology, 2010, 26(6): 633-634+637. |